825P CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting

Authors:
  • GRG. Rabinowits
    G. Rabinowits
  • JHJ. Homsi
    J. Homsi
  • SPS.J. Park
    S.J. Park
  • NKN. Khushanlani
    N. Khushanlani
  • TPT. Panella
    T. Panella
  • DED.M. Ellison
    D.M. Ellison
  • RGR.W. Gentry
    R.W. Gentry
  • SVS.S. Venna
    S.S. Venna
  • JSJ. Strasswimmer
    J. Strasswimmer
  • RZR.M. Zuniga
    R.M. Zuniga
  • SCS. Chandra
    S. Chandra
  • ERE.S. Ruiz
    E.S. Ruiz

Abstract
No abstract available